Target intelligence / Profile preview

Bovine viral diarrhea virus glycoprotein E2 (E2)

Target
E2
Molecular classification
Envelope glycoprotein, Viral fusion machinery component
01

Overview

Bovine viral diarrhea virus glycoprotein E2 (BVDV E2) is an envelope protein essential for pestivirus entry into host cells, forming disulfide-linked homodimers and heterodimers with E1 that mediate receptor binding and membrane fusion.[1][4] Its ectodomain features a unique three-domain architecture: two Ig-like domains (I and II) followed by an elongated β-stranded domain III with a novel fold, including a conserved histidine (His762) for pH sensing during endosomal acidification and extensive glycosylation and disulfide bonds for stability.[1] E2 determines cellular tropism via interactions with receptors like CD46 and harbors major neutralizing antibody epitopes, particularly in domains I and II.[1][4] Structurally, it lacks classic fusion motifs, suggesting E1 as the primary fusogen with E2 providing scaffold support, a model relevant to related hepatitis C virus.[1] BVDV particles, enriched in cholesterol and sphingolipids, display low E2 abundance on their ~50 nm envelope, highlighting E2's role in morphogenesis and entry.[2][4] As a veterinary pathogen target, E2 inhibition could block bovine infections, though no approved drugs exist.[3][4]

Other names
BVDV E2pestivirus E2
02

Biological functions

Virus cell entryReceptor binding (CD46 or CD81)Membrane fusion (as coeffector with E1)Viral tropism determinationNeutralizing antibody epitopes
03

Disease associations

Infection (bovine viral diarrhea in cattle)

Beyond the preview

Go deeper on Bovine viral diarrhea virus glycoprotein E2 (E2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bovine viral diarrhea virus glycoprotein E2 (E2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call